Odulair completes delivery and medical staff training of isolation unit exceeding CDC and U.S. healthcare code requirements within 35 days after receipt of order

 

Cheyenne, WY (December 8, 2014)  Odulair™, LLC today announced the speedy delivery of their patent pending Infectious Disease Isolation Unit that exceeds CDC and U.S. healthcare code building requirements for treating highly contagious patients in a U.S. hospital. The Odulair Infectious Disease Isolation Unit was built, delivered, installed on site, and the medical team was trained all within 35 days of the receipt of the customer’s order.

 

Odulair is well known as the world’s first provider of Ebola isolation units and the only provider with patented recursive isolation technology that provides all three types of isolation required for containment of Ebola patients along with technology that actively creates a safe haven protective environment for health care workers. The unique Odulair Isolation Unit provides recursive protection with numerous increasing layers of airborne infection isolation like the layers of an onion, as the proximity to the patient or contagion decreases. The patent-pending Odulair Infectious Disease Isolation Unit was designed to address known and potential modes of transmission of all highly contagious diseases including airborne, particulate, and bodily fluids.

 

The isolation unit far exceeds the existing level of hospital safety for health care workers by providing a positive pressure protective environment, similar to an operating theater environment, preventing airborne contaminants from entering into the medical staff work area. This is the only isolation unit available worldwide that actively protects the medical staff against known and possible airborne transmission.

 

The Odulair Infectious Disease Isolation Unit also incorporates the latest technological advances such as the InTouch Health RP-VITA, the world’s only Class II robot medical device enabling high acuity telemedicine care delivery. The specialized RP-VITA autonomous robot decreases the requirement of the medical staff to enter into the patient isolation room by providing automated delivery services for medications, food, and other supplies. Each of these advances furthers the Odulair mission of actively protecting health care workers from known and possible modes of infectious disease transmission.

 

“This is the only isolation unit worldwide that exceeds the requirements for Ebola isolation including bodily fluids, airborne particles, and aerosol and potentially airborne infection isolation that we have encountered in working with our West African colleagues treating Ebola patients,” said Dr. Anita Chambers, President of Odulair, LLC. “This Infectious Disease Isolation Ward provides an immediate solution for hospitals as they prepare to treat highly contagious patients such as those with Ebola, TB, Varicella, and other infectious diseases,” Chambers said.

 

The Odulair Infectious Disease Isolation Unit can be utilized in conjunction with an existing hospital, or independent as a complete, self-contained infectious disease treatment facility. The design provides easy scalability to increase the number of patient isolation rooms. The facility can include a power generation system and waste management system meeting all requirements to eliminate highly contagious diseases. The complete facility can be built, delivered, and operational in less than six weeks to meet the immediate need.